Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
02/02/2000 | EP0975741A2 Alpha/beta hydrolase-fold enzymes |
02/02/2000 | EP0975739A1 Stimulation, culture and preservation of pancreatic and other cells |
02/02/2000 | EP0975673A2 Determination of recombinant glycosylated proteins and peptides in biological fluids |
02/02/2000 | EP0975672A1 Antibodies for inhibiting blood coagulation and methods of use thereof |
02/02/2000 | EP0975668A1 MODIFIED TNF$g(a) MOLECULES, DNA ENCODING SUCH MODIFIED TNF$g(a) MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNF$g(a) MOLECULES AND DNA |
02/02/2000 | EP0975666A2 Compositions and methods for the treatment and diagnosis of breast cancer |
02/02/2000 | EP0975664A1 Aatt promoter element and transcription factor |
02/02/2000 | EP0975657A1 Method of purifying protein from inclusion bodies |
02/02/2000 | EP0777683B1 Antiprotozoal cyclic tetrapeptides |
02/02/2000 | EP0729580B1 Method of identifying hdm-2-specific antibodies |
02/02/2000 | EP0713532B1 Modified maxadilan protein, its preparation and use, and dna encoding the protein |
02/02/2000 | EP0713529B1 Growth differentiation factor of the TGF-B family |
02/02/2000 | EP0539530B1 Purification directed cloning of peptides |
02/02/2000 | EP0397834B1 Method for identifying active domains and amino acid residues in polypeptides and hormone variants |
02/01/2000 | US6020479 Amino acid transporters and uses |
02/01/2000 | US6020477 DNA sequences coding for the human proteins Tx and Ty related to the interleukin-1β converting enzyme |
02/01/2000 | US6020468 Antibodies directed against binding-associated epitopes |
02/01/2000 | US6020466 Myeloid cell leukemia associated gene mcl-1 |
02/01/2000 | US6020464 Isolated Smad protein |
02/01/2000 | US6020462 Nucleic acids encoding the hypoxia inducible factor-1 |
02/01/2000 | US6020309 Pharmaceuticals based on papillomaviruses |
02/01/2000 | US6020197 Neuroblasts are dependant upon about 1 to 100 ng/ml of bfgf for long term maintenance. |
02/01/2000 | US6020195 Antibodies against hepatitis G virus and their use for the diagnostic detection of HGV and as a therapeutic agent |
02/01/2000 | US6020192 Genes adapted for high level expression in mammalian cells, especially those of human origin. |
02/01/2000 | US6020189 Fibroblast growth factor homologous factors (FHFs) and methods of use |
02/01/2000 | US6020188 Polynucleotides encoding platelet endothelial cell adhesion molecule (PECAM-1) and fragments thereof |
02/01/2000 | US6020179 Nucleic acids encoding human tyrosine phosphatases |
02/01/2000 | US6020170 Method of preparing a monoclonal antibody |
02/01/2000 | US6020169 Production of secreted foreign polypeptides in plant cell culture |
02/01/2000 | US6020168 Porcine CNP gene and precursor protein |
02/01/2000 | US6020165 Cytikine signal regulators |
02/01/2000 | US6020164 Human RNA binding proteins |
02/01/2000 | US6020163 Lipocalin homolog |
02/01/2000 | US6020161 PIGR-1, a member of immunoglobulin gene superfamily |
02/01/2000 | US6020158 Intracellular g-protein complex which mediates further intracellular signaling activities generally the production of second messengers such as cyclic amp (camp), phospholipase c, inositol triphosphate or ion channel proteins. |
02/01/2000 | US6020157 Polynucleotides encoding HFGAN72X receptor |
02/01/2000 | US6020153 Chimeric antibodies |
02/01/2000 | US6020152 Lymphocyte-associated cell surface protein |
02/01/2000 | US6020144 These organisms have evolved a sophisticated ability to infect a host and evade their host's immune defenses. |
02/01/2000 | US6020143 The invention is concerned with the identification, isolation and cloning of genes which are associated with alzheimer's disease. |
02/01/2000 | US6020142 Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders |
02/01/2000 | US6019987 Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof |
02/01/2000 | US6019982 Mutant enterotoxin effective as a non-toxic oral adjuvant |
02/01/2000 | US6019980 Nucleic acid respiratory syncytial virus vaccines |
02/01/2000 | US6019973 Vaccine against enterotoxin-induced illness. |
02/01/2000 | CA2218491C Novel methods for the assay of troponin i and t and complexes of troponin i and t and selection of antibodies for use in immunoassays |
02/01/2000 | CA2171982C Drug binding protein |
02/01/2000 | CA2069085C Activatable fibrinolytic and anti-thrombotic proteins |
02/01/2000 | CA2047681C Vaccines for nontypable haemophilus influenzae |
02/01/2000 | CA2035039C Recombinant poxvirus and streptococcal m protein vaccine |
02/01/2000 | CA2009198C Monoclonal antibody for differentiating hiv-2 from hiv-1 seropositive individuals |
02/01/2000 | CA1340888C Vaccines and diagnostic assays for haemophilus influenzae |
01/27/2000 | WO2000004172A1 Method of making proteins in transformed yeast cells |
01/27/2000 | WO2000004170A1 Cleavage of caulobacter produced recombinant fusion proteins |
01/27/2000 | WO2000004150A1 Human presenilin-associated protein |
01/27/2000 | WO2000004149A2 Compositions and methods for therapy and diagnosis of prostate cancer |
01/27/2000 | WO2000004148A1 Tissue factor protein variants with increased affinity for coagulation factor fvii/fviia |
01/27/2000 | WO2000004147A1 Differentiation regulatory factor expressed specifically in testis |
01/27/2000 | WO2000004140A1 71 human secreted proteins |
01/27/2000 | WO2000004137A1 Human aspartic proteases |
01/27/2000 | WO2000004045A1 Axor10, a g-protein coupled receptor |
01/27/2000 | WO2000004043A1 Protease susceptibility ii |
01/27/2000 | WO1999061630A3 Chimeric molecules comprising an extracellular ligand binding domain of a receptor and an ige fc or constant region, and their use in an assay system |
01/27/2000 | WO1999060127A3 Il-17 homologous polypeptides and therapeutic uses thereof |
01/27/2000 | WO1999054465A9 Gene encoding syntaxin interacting protein |
01/27/2000 | WO1999023227A9 Hyaluronan synthase gene and uses thereof |
01/27/2000 | CA2337635A1 Method of making proteins in transformed yeast cells |
01/27/2000 | CA2335274A1 Tissue factor protein variants with increased affinity for coagulation factor fvii/fviia |
01/27/2000 | CA2334038A1 Compositions and methods for therapy and diagnosis of prostate cancer |
01/27/2000 | CA2333917A1 71 human secreted proteins |
01/27/2000 | CA2333467A1 Human presenilin-associated protein |
01/27/2000 | CA2303062A1 Human aspartic proteases |
01/26/2000 | EP0974671A1 Method for diagnosing bone dysbolism |
01/26/2000 | EP0974664A2 Human polypeptides and polynucleotides homolog to mouse testes-specific angiotensins converting enzyme |
01/26/2000 | EP0974663A1 Lipoprotein associated phospholipase A2, inhibitors thereof and use of same in diagnosis and therapy |
01/26/2000 | EP0974659A2 Viral nucleotide sequences |
01/26/2000 | EP0974655A2 G-CSF analog compositions and methods |
01/26/2000 | EP0974654A2 Method for secretory production of human growth hormone |
01/26/2000 | EP0974653A2 Human gastric cancer antigen gene and protein |
01/26/2000 | EP0974651A1 Physiologically active protein originating in mammals |
01/26/2000 | EP0974057A1 Methods to detect hk2 polypeptides |
01/26/2000 | EP0973944A1 Reagents and methods useful for detecting diseases of the gastrointestinal tract |
01/26/2000 | EP0973940A1 AN $i(IN VITRO) METHOD FOR CONSTRUCTION OF A DNA LIBRARY |
01/26/2000 | EP0973923A1 IMPROVED ASSAYS FOR $g(b)-AMYLOID PROCESSING |
01/26/2000 | EP0973909A2 Process for extracting and purifying recombinant, non-lipidised osp-protein |
01/26/2000 | EP0973903A2 Protein for inhibiting apoptosis |
01/26/2000 | EP0973900A1 flt3 LIGAND CHIMERIC PROTEINS |
01/26/2000 | EP0973898A2 SECRETED EXPRESSED SEQUENCE TAGS (sESTs) |
01/26/2000 | EP0973897A1 Human tumor-associated membrane protein |
01/26/2000 | EP0973894A1 Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use |
01/26/2000 | EP0973892A2 28 human secreted proteins |
01/26/2000 | EP0973890A2 Secreted proteins and polynucleotides encoding them |
01/26/2000 | EP0973889A1 Human calcium channels alfa1 subunits and related probes, cell lines and methods |
01/26/2000 | EP0973884A1 Phosphate-deficiency inducible promoter |
01/26/2000 | EP0973876A1 DNA ENCODING $i(PNEUMOCYSTIS CARINII) PROTEASE |
01/26/2000 | EP0973869A1 Method for increasing the growth of plant cell cultures |
01/26/2000 | EP0973867A1 Cell culture media for enhanced protein production |
01/26/2000 | EP0973805A1 Method for production of antibodies to specific sites of rapamycin |
01/26/2000 | EP0973804A2 Anti-vegf antibodies |
01/26/2000 | EP0973800A1 Novel receptor |